Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 352 to 401 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
352\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ALPHA-ACTININ 4 (NON-MUSCLE ALPHA-ACTININ 4) (F-ACTIN CROSS LINKING PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.5119\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5.35346\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.282415485\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ACTN4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
353\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSCRIPTION INITIATION FACTOR TFIID 55 KDA SUBUNIT (TAFII-55) (TAFII55). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.124527\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.441415\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.282108673\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TAF7\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
354\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"TATA BOX BINDING PROTEIN-ASSOCIATED FACTOR, RNA POLYMERASE II, Q; TAF7-LIKE RNA POLYMERASE II, TATA BOX BINDING PROTEIN (TBP)-ASSOCIATED FACTOR, 50 KD; TBP-ASSOCIATED FACTOR, RNA POLYMERASE II, Q. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.103996\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.36903\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.281809067\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TAF7L\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
355\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EXOCYST COMPLEX COMPONENT SEC15B. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.117602\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.417668\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.281568135\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EXOC6B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
356\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0483186\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.171674\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.281455549\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}}\\\cline{1-1}\cline{3-5}
\parbox{\wcA}{\vspace{3pt}\noindent
357\vspace{3pt}}&&\parbox{\wcC}{\vspace{3pt}\noindent
0.042516\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.151058\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.281454805\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
358\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTEIN AD-016 (PROTEIN CGI-116) (X0009). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.3145\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.11741\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.281454435\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CCDC53\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
359\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"CLEAVAGE AND POLYADENYLATION SPECIFIC FACTOR 5, 25 KD SUBUNIT; PRE-MRNA CLEAVAGE FACTOR IM (25KD); PRE-MRNA CLEAVAGE FACTOR IM, 25KD SUBUNIT. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.288916\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.0267\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.281402552\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NUDT21\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
360\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EXOCYST COMPLEX COMPONENT SEC15A. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.138286\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.49236\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.280863596\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EXOC6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
361\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
EXOCYST COMPLEX COMPONENT SEC8. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.090885\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.324189\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.280345724\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
EXOC4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
362\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
OSTEOCLAST STIMULATING FACTOR 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0741822\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.264688\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.2802628\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
OSTF1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
363\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SPLICING FACTOR 3B SUBUNIT 4 (SPLICEOSOME ASSOCIATED PROTEIN 49) (SAP 49) (SF3B50) (PRE-MRNA SPLICING FACTOR SF3B 49 KDA SUBUNIT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0893365\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.318821\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.280208957\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SF3B4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
364\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"C316G12.2 (NOVEL PROTEIN SIMILAR TO PREDICTED YEAST, WORM AND ARCHAE- BACTERIAL PROTEINS) (SIMILAR TO UND313) (S. CERVISIAE) (HYPOTHETICAL PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.131623\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.469919\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.280097208\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C16orf42\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
365\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
G-RICH SEQUENCE FACTOR-1 (GRSF-1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.170665\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.610067\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.279747962\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GRSF1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
366\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H3 (HNRNP H3) (HNRNP 2H9). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.179445\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.641462\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.279743773\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HNRPH3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
367\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN F (HNRNP F). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.198738\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.710442\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.279738529\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HNRPF\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
368\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H (HNRNP H). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.219762\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.785612\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.279733507\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HNRPH1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
369\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN H' (HNRNP H') (FTP-3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.222111\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.794014\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.279731844\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
HNRPH2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
370\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"COFILIN, NON-MUSCLE ISOFORM (18 KDA PHOSPHOPROTEIN) (P18). \vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0460179\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.164816\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.279207723\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
CFL1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
371\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DESTRIN (ACTIN-DEPOLYMERIZING FACTOR) (ADF). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
DSTN\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
372\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"COFILIN, MUSCLE ISOFORM (COFILIN 2). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
CFL2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
373\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.034272\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.122748\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.279206179\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
374\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UBIQUITIN FUSION DEGRADATION PROTEIN 1 HOMOLOG (UB FUSION PROTEIN 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.379312\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.35854\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.279205618\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
UFD1L\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
375\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"DYNEIN INTERMEDIATE CHAIN 2, CYTOSOLIC (DH IC-2) (CYTOPLASMIC DYNEIN INTERMEDIATE CHAIN 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.119541\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.428154\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.279200942\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DYNC1I2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
376\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRE-MRNA SPLICING FACTOR PRP17 (HPRP17) (EH-BINDING PROTEIN 3) (EHB3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.274292\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.982579\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.279155162\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CDC40\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
377\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0389719\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.139616\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.279136345\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CCDC12\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
378\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PTB DOMAIN ADAPTOR PROTEIN CED-6; ENGULFMENT ADAPTER PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0573826\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.205572\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.279136264\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GULP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
379\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CROOKED NECK-LIKE PROTEIN 1 (CROOKED NECK HOMOLOG) (HCRN) (CGI-201) (MSTP021). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.802935\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.8765\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.279136103\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CRNKL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
380\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CALCYPHOSINE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0480742\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.172225\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.279136014\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CAPS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
381\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0666911\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.23892\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.279135694\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CAPSL\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
382\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MITOCHONDRIAL IMPORT RECEPTOR SUBUNIT TOM20 HOMOLOG (MITOCHONDRIAL 20 KDA OUTER MEMBRANE PROTEIN) (OUTER MITOCHONDRIAL MEMBRANE RECEPTOR TOM20). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0530069\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.189914\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.279110018\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TOMM20\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
383\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PEROXISOMAL FARNESYLATED PROTEIN (33 KDA HOUSEKEEPING PROTEIN) (PEROXIN 19). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.245859\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.88087\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.27910929\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PEX19\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
384\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CDC42-INTERACTING PROTEIN 4 (THYROID RECEPTOR INTERACTING PROTEIN 10) (TRIP-10). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.448126\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.60594\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.279042804\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TRIP10\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
385\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"DYNEIN INTERMEDIATE CHAIN 1, CYTOSOLIC (DH IC-1) (CYTOPLASMIC DYNEIN INTERMEDIATE CHAIN 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.104222\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.373698\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.278893652\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DYNC1I1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
386\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"GRPE PROTEIN HOMOLOG 2, MITOCHONDRIAL PRECURSOR (MT-GRPE#2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0678064\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.243254\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.278747318\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GRPEL2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
387\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"GRPE PROTEIN HOMOLOG 1, MITOCHONDRIAL PRECURSOR (MT-GRPE#1) (HMGE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0851715\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.305551\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.278747247\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GRPEL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
388\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"SWI/SNF RELATED, MATRIX ASSOCIATED, ACTIN DEPENDENT REGULATOR OF CHROMATIN SUBFAMILY D MEMBER 1 (SWI/SNF COMPLEX 60 KDA SUBUNIT) (BRG1- ASSOCIATED FACTOR 60A). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.140567\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.504282\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.278746812\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SMARCD1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
389\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SWI/SNF-RELATED MATRIX-ASSOCIATED ACTIN-DEPENDENT REGULATOR OF CHROMATIN D2; RSC6P; MAMMALIAN CHROMATIN REMODELING COMPLEX BRG1-ASSOCIATED FACTOR 60B; SWP73-LIKE PROTEIN; CHROMATIN REMODELING COMPLEX BAF60B SUBUNIT; SWI/SNF COMPLEX 60 KDA SUBUNIT B. [Sour\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0474703\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.170299\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.278746792\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SMARCD2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
390\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SWI/SNF-RELATED MATRIX-ASSOCIATED ACTIN-DEPENDENT REGULATOR OF CHROMATIN D3; RSC6P; MAMMALIAN CHROMATIN REMODELING COMPLEX BRG1-ASSOCIATED FACTOR 60C; SWP73-LIKE PROTEIN; CHROMATIN REMODELING COMPLEX BAF60C SUBUNIT; SWI/SNF COMPLEX 60 KDA SUBUNIT C. [Sour\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.123465\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.44293\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.278746077\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SMARCD3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
391\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.368426\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.32182\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.278726302\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FNBP1L\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
392\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
40S RIBOSOMAL PROTEIN S26. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.135061\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.484774\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.278606113\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
393\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MITOCHONDRIAL IMPORT INNER MEMBRANE TRANSLOCASE SUBUNIT TIM22. \vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0993399\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.356562\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.278604843\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
TIMM22\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
394\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ATP SYNTHASE MITOCHONDRIAL F1 COMPLEX ASSEMBLY FACTOR 2. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
ATPAF2\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
395\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
UBIQUINOL-CYTOCHROME C REDUCTASE COMPLEX 14 KDA PROTEIN (EC 1.10.2.2) (COMPLEX III SUBUNIT VI) (QP-C). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
UQCRB\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
396\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0370257\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.132897\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.278604483\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TSR2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
397\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NHP2-LIKE PROTEIN 1 (HIGH MOBILITY GROUP-LIKE NUCLEAR PROTEIN 2 HOMOLOG 1) ([U4/U6.U5] TRI-SNRNP 15.5 KDA PROTEIN) (OTK27). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0337208\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.121119\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.278410489\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NHP2L1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
398\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUCLEAR FRAGILE X MENTAL RETARDATION PROTEIN INTERACTING PROTEIN 1; NUCLEAR FRAGILE X MENTAL RETARDATION INTERCATING PROTEIN 1; NUCLEAR FRAGILE X MENTAL RETARDATION PROTEIN-INTERACTING PROTEIN 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0673151\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.241784\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.278410068\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NUFIP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
399\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
THYROID RECEPTOR INTERACTING PROTEIN 3 (TRIP-3) (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0671887\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.24133\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.278410061\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ZNHIT3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
400\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TRANSCRIPTION INITIATION FACTOR IIB (GENERAL TRANSCRIPTION FACTOR TFIIB) (S300-II). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.101036\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.362904\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.278409717\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GTF2B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
401\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
M-PHASE INDUCER PHOSPHATASE 3 (EC 3.1.3.48) (DUAL SPECIFICITY PHOSPHATASE CDC25C). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.590395\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.12136\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.278309669\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CDC25C\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/